MYBL2 was expressed at significantly higher levels in primary untreated ovarian carcinoma as compared with borderline ovarian surface epithelial-stromal tumor (Figure 1C) and ranked as the fourth most differentially upregulated gene among an independent data set (t-test 18.076, p = 5.99E-31, fold change 2.555, data not shown) (6, 16, 18). This evidence concerns the gene MYBL2 and borderline epithelial tumor of ovary.